Quick Answer
HALOZYME THERAPEUTICS, INC. reported Shares Outstanding of 117.78 million shares for fiscal year 2025.
HALOZYME THERAPEUTICS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 117.78M | -4.3% |
| 2024 | 123.14M | -2.9% |
| 2023 | 126.77M | -6.2% |
| 2022 | 135.15M | -1.7% |
| 2021 | 137.50M | +1.8% |
| 2020 | 135.03M | -1.2% |
| 2019 | 136.71M | -5.5% |
| 2018 | 144.73M | +1.4% |
| 2017 | 142.79M | +10.3% |
| 2016 | 129.50M | +1.1% |
| 2015 | 128.15M | +1.9% |
| 2014 | 125.72M | +9.8% |
| 2013 | 114.53M | +1.6% |
| 2012 | 112.71M | +8.4% |
| 2011 | 103.99M | +3.4% |
| 2010 | 100.58M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 117.52M | -7.6% | -0.1% |
| June 30, 2025 | 117.62M | -7.0% | -4.5% |
| March 31, 2025 | 123.17M | -3.2% | +0.0% |
| December 31, 2024 | 123.14M | -2.9% | -3.2% |
| September 30, 2024 | 127.18M | -3.7% | +0.5% |
| June 30, 2024 | 126.53M | -4.0% | -0.5% |
| March 31, 2024 | 127.19M | -3.4% | +0.3% |
| December 31, 2023 | 126.77M | -6.2% | -4.0% |
- HALOZYME THERAPEUTICS, INC. showed a decrease of -4.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, HALOZYME THERAPEUTICS, INC.’s shares outstanding has grown by 17.1% (from 100.58 million shares to 117.78 million shares).
- The most recent figure is from HALOZYME THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: